We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+8.53%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+305.76%
AUM
$94B
AUM Growth
+$5.35B
(+6%)
Cap. Flow
-$10.2B
Cap. Flow
% of AUM
-10.87%
Top 10 Holdings %
Top 10 Hldgs %
22.25%
Holding
2,551
New
400
Increased
743
Reduced
692
Closed
262
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinnacle West Capital
PNW
|
+$455M |
| 2 |
PNC Financial Services
PNC
|
+$306M |
| 3 |
Otis Worldwide
OTIS
|
+$234M |
| 4 |
Colgate-Palmolive
CL
|
+$212M |
| 5 |
NorthWestern Energy
NWE
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$545M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$293M |
| 3 |
CSX Corp
CSX
|
+$210M |
| 4 |
Baxter International
BAX
|
+$171M |
| 5 |
Dollar Tree
DLTR
|
+$160M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.36% |
| 2 | Healthcare | 14.2% |
| 3 | Financials | 13.3% |
| 4 | Industrials | 9.5% |
| 5 | Consumer Discretionary | 9.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Century Communities
CCS
$2.03B
| $75K | ﹤0.01% |
918
+122
| +15% | +$8.72K |
|
1352
Global Ship Lease
GSL
$1.53B
| $75K | ﹤0.01% |
3,295
+2,524
| +327% | +$57.6K |
|
1353
Thor Industries
THO
$4.14B
| $75K | ﹤0.01% |
728
+270
| +59% | +$29.3K |
|
|
GBT
1354
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $75K | ﹤0.01% |
2,579
+617
| +31% | +$19.1K |
|
|
AGEN
1355
Agenus
AGEN
$290M
| $74K | ﹤0.01% |
1,179
-2,019
| -63% | -$159K |
|
1356
Concrete Pumping Holdings
BBCP
$491M
| $74K | ﹤0.01% |
9,054
| – | – |
|
1357
Globus Medical
GMED
$11.2B
| $74K | ﹤0.01% |
1,030
-11,853
| -92% | -$860K |
|
|
HSII
1358
DELISTED
Heidrick & Struggles
HSII
| $74K | ﹤0.01% |
1,697
+121
| +8% | +$5.5K |
|
1359
Regal Rexnord
RRX
$11.9B
| $74K | ﹤0.01% |
438
+142
| +48% | +$22.5K |
|
|
RWT
1360
Redwood Trust
RWT
$594M
| $74K | ﹤0.01% |
5,673
+5,184
| +1,060% | +$70.1K |
|
1361
Apyx Medical
APYX
$171M
| $73K | ﹤0.01% |
5,770
+478
| +9% | +$6.69K |
|
1362
Cracker Barrel
CBRL
$1.29B
| $73K | ﹤0.01% |
572
+293
| +105% | +$39.1K |
|
1363
CNB Financial Corp
CCNE
$1.03B
| $73K | ﹤0.01% |
2,776
+1,046
| +60% | +$27.4K |
|
1364
Franklin Covey
FC
$246M
| $73K | ﹤0.01% |
1,590
-306
| -16% | -$13.6K |
|
|
KYNB
1365
Kyntra Bio
KYNB
$29.4M
| $73K | ﹤0.01% |
207
-1,675
| -89% | -$522K |
|
1366
iShares Global 100 ETF
IOO
$9.25B
| $73K | ﹤0.01% |
+939
| New | +$71.1K |
|
1367
Lifecore Biomedical
LFCR
$190M
| $73K | ﹤0.01% |
+6,655
| New | +$64.6K |
|
1368
QuinStreet
QNST
$1.21B
| $73K | ﹤0.01% |
4,014
+1,978
| +97% | +$32.8K |
|
1369
Vericel Corp
VCEL
$2.31B
| $73K | ﹤0.01% |
1,869
+216
| +13% | +$9.47K |
|
1370
Acadia Pharmaceuticals
ACAD
$5.03B
| $72K | ﹤0.01% |
3,115
+506
| +19% | +$10.2K |
|
1371
Brink's
BCO
$4.62B
| $72K | ﹤0.01% |
+1,107
| New | +$71.3K |
|
1372
Douglas Emmett
DEI
$1.96B
| $72K | ﹤0.01% |
+2,158
| New | +$73K |
|
1373
Farmers National Banc Corp
FMNB
$929M
| $72K | ﹤0.01% |
3,895
+420
| +12% | +$7.47K |
|
1374
Generac Holdings
GNRC
$12.5B
| $72K | ﹤0.01% |
206
-47,723
| -100% | -$19.8M |
|
1375
Onto Innovation
ONTO
$15.3B
| $72K | ﹤0.01% |
+716
| New | +$61.8K |
|
Similar funds
QCM
Lazard Asset Management's Q4 2021 Portfolio in Review
As of Q4 2021, Lazard Asset Management held 2,551 positions worth $94B, up 6% from $88.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Lazard Asset Management withdrew a net $10.2B in Q4 2021, closing 262 positions and reducing 692 holdings. Its most notable exit was Innospec, an estimated $21M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lazard Asset Management opened a new position in Wells Fargo 7.5% Non Cumv Perp Conv worth $922K.
- Lazard Asset Management's largest Q4 2021 buy was Wells Fargo 7.5% Non Cumv Perp Conv: 61,920 shares worth $922K.
- Lazard Asset Management added most to Pinnacle West Capital in Q4 2021, an estimated $455M increase.
- Lazard Asset Management's biggest Q4 2021 reduction was JPMorgan Chase, cutting an estimated $545M.
- Lazard Asset Management fully exited Innospec in Q4 2021, selling an estimated $21M.
- Lazard Asset Management's ten largest holdings make up 22% of its $94B portfolio in Q4 2021.
- Lazard Asset Management opened 400 new positions and closed 262 in Q4 2021.
- Lazard Asset Management's portfolio value rose 6% quarter-over-quarter to $94B.
Based on Lazard Asset Management's 13F filing for Q4 2021, filed 9 Feb 2022.